title: Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?
authors.forename: Bruce G
authors.initials: BG
authors.lastname: Haffty
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Buchholz
authors.forename: Beryl
authors.initials: B
authors.lastname: McCormick
mesh_terms: D000208:Acute Disease; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental / Q000592:standards; D009367:Neoplasm Staging; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010147:Pain Measurement; D018579:Patient Selection; D011787:Quality of Health Care; D011788:Quality of Life; D011829:Radiation Dosage; D011855:Radiodermatitis / Q000209:etiology / Q000517:prevention & control*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects / Q000592:standards; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects / Q000592:standards; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome